Design and synthesis of the novel, selective WZ4002 analogue as EGFR-L858R/T790M tyrosine kinase inhibitors for targeted drug therapy in non-small-cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Design and synthesis of the novel, selective WZ4002 analogue as EGFR-L858R/T790M tyrosine kinase inhibitors for targeted drug therapy in non-small-cell lung cancer (NSCLC)

Published:2022-04 Issue: Volume:1254 Page:132313
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Pawara Rahul,Ahmad Iqrar,Nayak Deepika,Belamkar Sateesh,Surana Sanjay,Kundu Chanakya Nath,Patil Chandragauda,Patel Harun

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference60 articles.

1. Colorectal cancer statistics 2020;Siegel;CA Cancer J. Clin.,2020

2. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors from the natural origin: a recent perspective;Patel;Anticancer Agents Med. Chem.,2015

3. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways;Sordella;Science,2004

4. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255;Tracy;Cancer Res.,2004

5. Inhibition of EGFR signaling: all mutations are not created equal;Gazdar;PLoS Med.,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular docking, QSAR, and simulation analyses of EGFR-targeting phytochemicals in non-small cell lung cancer;Journal of Molecular Structure;2025-02

2. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

3. Exploring the structural activity relationship of the Osimertinib: A covalent inhibitor of double mutant EGFRL858R/T790M tyrosine kinase for the treatment of Non-Small Cell Lung Cancer (NSCLC);Bioorganic & Medicinal Chemistry;2024-07

4. Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFR^WT and EGFR^T790M: design, synthesis, ADMET and molecular docking;RSC Advances;2024

5. Novel bioactive 2‐phenyl‐4‐aminopyrimidine derivatives as EGFR^{Del19/T790M/C797S} inhibitors for the treatment of non‐small cell lung cancer;Archiv der Pharmazie;2023-11-27